SCHEMBL6657077

SCHEMBL6657077

CC(=O)c1c(C)nc2ccccc2c1NCc1ccc(Br)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
ALDH1A1 P00352 2/20 0.42
PDE5A O76074 3/20 0.41
KMT2A Q03164 4/20 0.40
POLB P06746 2/20 0.40
RAD52 P43351 1/20 0.40
HTT P42858 3/20 0.40
MEN1 O00255 2/20 0.39
ACHE P22303 2/20 0.39
HCRTR1 O43613 1/20 0.39
BCHE P06276 1/20 0.39
CD38 P28907 1/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TACR1 P25103 1/20 0.38
APP P05067 1/20 0.38
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7647477 0.88 TP53 (0.45) TP53HSD17B10ALDH1A1KMT2APOLB
SCHEMBL6650864 0.85 TP53 (0.51) TP53HSD17B10ALDH1A1KMT2APOLB
SCHEMBL7649838 0.84 APP (0.54) TP53HSD17B10ALDH1A1KMT2APOLB
SCHEMBL9821131 0.83 KMT2A (0.59) TP53HSD17B10ALDH1A1KMT2APOLB
Hydrochloric Acid SCHEMBL9821072 0.82 KMT2A (0.57) TP53HSD17B10ALDH1A1KMT2APOLB
SCHEMBL6652248 0.81 ALDH1A1 (0.49) TP53HSD17B10ALDH1A1KMT2AHTT
SCHEMBL9821213 0.80 HTT (0.52) TP53HSD17B10ALDH1A1KMT2APOLB
SCHEMBL6658584 0.80 HSD17B10 (0.51) TP53HSD17B10ALDH1A1KMT2APOLB
Hydrochloric Acid SCHEMBL10567928 0.79 KMT2A (0.53) TP53HSD17B10ALDH1A1KMT2APOLB
SCHEMBL7653573 0.77 APP (0.52) TP53HSD17B10ALDH1A1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218401-B1 4-BENZYLAMINOQUINOLINE CONJUGATES WITH BILE ACID AND THEIR HETEROANALOGUES, METHODS FOR PRODUCING THE SAME, MEDICAMENTS CONTAINING THESE COMPOUNDS AND THEIR USE AVENTIS PHARMA GMBH (DE) 2004-06-16 EP disclosed
EP-1218401-A1 4-BENZYLAMINOQUINOLINE CONJUGATES WITH BILE ACID AND THEIR HETEROANALOGUES, METHODS FOR PRODUCING THE SAME, MEDICAMENTS CONTAINING THESE COMPOUNDS AND THEIR USE Aventis Pharma Deutschland GmbH (DE) 2002-07-03 EP disclosed
US-6339077-B1 FOR PROPHYLAXIS OR OF GALLSTONES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-01-15 US disclosed
WO-2001021642-A1 4-BENZYLAMINOQUINOLINE CONJUGATES WITH BILE ACID AND THEIR HETEROANALOGUES, METHODS FOR PRODUCING THE SAME, MEDICAMENTS CONTAINING THESE COMPOUNDS AND THEIR USE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-03-29 WO disclosed